Compact blood hematocrit sensing device

US10598583B1 · US · B1

Patent metadata
FieldValue
Publication numberUS-10598583-B1
Application numberUS-201715600116-A
CountryUS
Kind codeB1
Filing dateMay 19, 2017
Priority dateMay 31, 2016
Publication dateMar 24, 2020
Grant dateMar 24, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compact devices are provided to measure hematocrit of a blood sample. These devices include first and second chambers that receive respective portions of a blood sample via respective filters. The material of the filters prevents passage of red blood cells while permitting passage of blood plasma. One of the filters has one or more holes to permit the passage of whole blood. Thus, when an example device is presented with a sample of blood, one of the chambers contains whole blood and the other contains blood from which the red blood cells have been filtered. Electrodes in each of the chambers can then be used to detect the impedances of the whole blood and the filtered blood, and the detected impedances can be used to determine a hematocrit of the sample of blood.

First claim

Opening claim text (preview).

What is claimed is: 1. A system comprising: a conduit; a first filter in fluid communication with the conduit, wherein the first filter comprises a material that blocks passage of red blood cells; a second filter in fluid communication with the conduit, wherein the second filter comprises a material that blocks passage of red blood cells, and wherein the second filter has at least one hole in the material through which red blood cells can pass; a first chamber in fluid communication with the conduit via the first filter, wherein the first chamber comprises at least one electrode; and a second chamber in fluid communication with the conduit via the second filter, wherein the second chamber comprises at least one electrode. 2. The system of claim 1 , further comprising a controller that is operably coupled to the at least one electrode of the first chamber and the at least one electrode of the second chamber, wherein the controller comprises electronics to: detect, using the at least one electrode of the first chamber, a first impedance of blood in the first chamber, wherein the blood in the first chamber comprises a first portion of a volume of blood received into the conduit; detect, using the at least one electrode of the second chamber, a second impedance of blood in the second chamber, wherein the blood in the second chamber comprises a second portion of the volume of blood received into the conduit; and determine, based on the first detected impedance and the second detected impedance, a hematocrit of the volume of blood received into the conduit. 3. The system of claim 1 , wherein a hydrophilic material is disposed within at least one of the first chamber or the second chamber, wherein the hydrophilic material provides a capillary force to draw blood into the at least one of the first chamber or the second chamber via the conduit. 4. The system of claim 3 , wherein the first chamber and the second chamber comprise respective vents allowing for the displacement of gas from the first chamber and the second chamber when blood enters the first chamber and the second chamber from the conduit. 5. The system of claim 1 , further comprising a suction source, wherein the suction source provides a suction to draw blood into each of the first chamber and the second chamber via the conduit. 6. The system of claim 5 , wherein the first chamber and the second chamber comprise a first gas-permeable membrane and a second gas-permeable membrane, respectively, wherein the first and second gas-permeable membranes are not permeable to blood plasma, and wherein at least a portion of the provided suction is provided to the first and second chambers via the first and second gas-permeable membranes. 7. The system of claim 5 , wherein the suction source comprises an evacuated volume, wherein the evacuated volume comprises the first chamber and the second chamber, and wherein the system further comprises: a needle; an injector, wherein the injector is operable to drive the needle into the skin to form a puncture in the skin and subsequently to retract the needle from the skin; and a seal, wherein the injector drives the needle through the seal to form at least one hole in the seal, and wherein the suction provided by the suction source draws blood from the formed puncture in the skin into the conduit through the formed at least one hole in the seal. 8. The system of claim 5 , wherein the suction source comprises an evacuated volume, wherein the evacuated volume comprises the first chamber and the second chamber, wherein the evacuated volume further comprises a first evacuated volume and a second evacuated volume, wherein the first evacuated volume applies suction to the first chamber, wherein the second evacuated volume applies suction to the second chamber, and wherein the first and second evacuated volumes have respective sizes. 9. The system of claim 1 , further comprising an anti-coagulant substance disposed within at least one of the conduit, the first chamber, the second chamber, the first filter, or the second filter. 10. A method comprising: receiving, through a conduit, a volume of blood; receiving, into a first chamber, a portion of the volume of blood via a first filter, wherein the first chamber comprises at least one electrode, and wherein the first filter comprises a material that blocks passage of red blood cells; receiving, into a second chamber, a portion of the volume of blood via a second filter, wherein the second chamber comprises at least one electrode, wherein the second filter comprises a material that blocks passage of red blood cells, and wherein the second filter has at least one hole in the material through which red blood cells can pass; detecting, using the at least one electrode of the first chamber, a first impedance of blood in the first chamber; detecting, using the at least one electrode of the second chamber, a second impedance of blood in the second chamber; and determining, based on the first detected impedance and the second detected impedance, a hematocrit of the volume of blood received into the conduit. 11. The method of claim 10 , wherein detecting, using the at least one electrode of the first chamber, a first impedance of blood in the first chamber comprises applying an alternating current via the at least one electrode of the first chamber. 12. The method of claim 10 , wherein determining, based on the first detected impedance and the second detected impedance, a hematocrit of the volume of blood received into the conduit comprises determining a ratio of the first detected impedance and the second detected impedance. 13. The method of claim 10 , wherein a hydrophilic material is disposed within at least one of the first chamber or the second chamber, wherein the hydrophilic material provides a capillary force to draw blood into the at least one of the first chamber or the second chamber from the conduit. 14. The method of claim 10 , further comprising: operating an injector to drive a needle into skin to form a puncture in the skin and subsequently to retract the needle from the skin, wherein operating the injector to drive the needle into the skin further comprises driving the needle through a seal to form at least one hole in the seal, and wherein suction is provided by a suction source to draw the volume of blood from the formed puncture in the skin through the formed at least one hole in the seal into the conduit. 15. The method of claim 14 , wherein the injector comprises: (a) a chamber, wherein the needle is disposed at least partially within the chamber, (b) a piston disposed in the chamber, wherein the needle is coupled to the piston, and wherein the piston can slidably move within the chamber, and (c) a propellant, wherein operating the injector to drive the needle into the skin comprises igniting the propellant to slidably move the piston within the chamber to drive the needle to pierce the seal and further to drive the needle into skin. 16. A system comprising: a conduit; a first filter in fluid communication with the conduit, wherein the first filter comprises a material that blocks passage of red blood cells; a second filter in fluid communication with the conduit, wherein the second filter comprises a material that blocks passage of red blood cells, wherein the second filter has at least one hole in the material through which red blood cells can pass; a first chamber in fluid communication with the conduit via the first filter, wherein the first chamber comprises at least one electrode; a second chamber in fluid communication with

Assignees

Inventors

Classifications

  • for hematocrite determination · CPC title

  • G01N15/05Primary

    in blood · CPC title

  • Blood {(chemical methods for determining blood cell populations G01N33/5094; chemical analysis of blood groups or blood types G01N33/80)} · CPC title

  • Characterized by propelling the piercing element in an axial direction relative to the disc · CPC title

  • Each piercing element being stocked in a separate isolated compartment · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10598583B1 cover?
Compact devices are provided to measure hematocrit of a blood sample. These devices include first and second chambers that receive respective portions of a blood sample via respective filters. The material of the filters prevents passage of red blood cells while permitting passage of blood plasma. One of the filters has one or more holes to permit the passage of whole blood. Thus, when an examp…
Who is the assignee on this patent?
Verily Life Sciences Llc
What technology area does this patent fall under?
Primary CPC classification G01N15/05. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).